Which has stronger earnings and valuation, MRV or APH?

Aphria has higher revenue and earnings than Nuvo Pharmaceuticals. Aphria is trading at a lower price-to-earnings ratio than Nuvo Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Nuvo Pharmaceuticals C$8.72B 3.14 C$15.17M C$2.91 10.48 Aphria C$29.01B 1.02 C$4.92B C$4.00 6.01

Which has higher earnings and valuation, VRX or APH?

Aphria has higher revenue and earnings than Valeant Pharmaceuticals International. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Valeant Pharmaceuticals International N/A N/A N/A N/A N/A Aphria C$29.01B 1.02 C$4.92B C$4.00 6.01

Is VRX or APH more profitable?

Company Net Margins Return on Equity Return on Assets Valeant Pharmaceuticals International N/A N/A N/A Aphria N/A N/A N/A

Which has stronger earnings and valuation, APH or APHA?

Aphria has higher revenue and earnings than Aphria. Aphria is trading at a lower price-to-earnings ratio than Aphria, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aphria C$29.01B 1.02 C$4.92B C$4.00 6.01 Aphria C$611.06M 0.00 -C$637.39M -C$2.01 N/A

Is APH or APHA more profitable?

Company Net Margins Return on Equity Return on Assets Aphria N/A N/A N/A Aphria N/A N/A N/A

Do analysts rate BHC or APH?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bausch Health Companies 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Aphria 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher earnings and valuation, BHC or APH?

Aphria has higher revenue and earnings than Bausch Health Companies. Bausch Health Companies is trading at a lower price-to-earnings ratio than Aphria, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Bausch Health Companies C$10.85B 0.33 -C$125.65M -C$2.94 N/A Aphria C$29.01B 1.02 C$4.92B C$4.00 6.01

Which has better valuation & earnings, APH or MJN?

Aphria has higher revenue and earnings than Cronos Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aphria C$29.01B 1.02 C$4.92B C$4.00 6.01 Cronos Group N/A N/A N/A N/A N/A

Is APH or MJN more profitable?

Company Net Margins Return on Equity Return on Assets Aphria N/A N/A N/A Cronos Group N/A N/A N/A

Aphria (APH) Competitors

C$24.02 0.00 (0.00%)

As of 07/31/2026 03:59 PM Eastern

Compare

APH vs. MRV, VRX, APHA, BHC, and MJN

Should you buy Aphria stock or one of its competitors? MarketBeat compares Aphria with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Aphria include Nuvo Pharmaceuticals (MRV), Valeant Pharmaceuticals International (VRX), Aphria (APHA), Bausch Health Companies (BHC), and Cronos Group (MJN). These companies are all part of the "pharmaceuticals" industry.

How does Aphria compare to Nuvo Pharmaceuticals?

Nuvo Pharmaceuticals (TSE:MRV) and Aphria (TSE:APH) are both large-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, profitability, earnings, institutional ownership, analyst recommendations, valuation, dividends and media sentiment.

Aphria has higher revenue and earnings than Nuvo Pharmaceuticals. Aphria is trading at a lower price-to-earnings ratio than Nuvo Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nuvo Pharmaceuticals	C$8.72B	3.14	C$15.17M	C$2.91	10.48
Aphria	C$29.01B	1.02	C$4.92B	C$4.00	6.01

Nuvo Pharmaceuticals has a beta of 0.917796, indicating that its stock price is 8% less volatile than the broader market. Comparatively, Aphria has a beta of 3.455044, indicating that its stock price is 246% more volatile than the broader market.

Nuvo Pharmaceuticals has a net margin of 20.95% compared to Aphria's net margin of 0.00%. Nuvo Pharmaceuticals' return on equity of 1,180.47% beat Aphria's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nuvo Pharmaceuticals	20.95%	1,180.47%	5.85%
Aphria	N/A	N/A	N/A

In the previous week, Nuvo Pharmaceuticals' average media sentiment score of 0.00 equaled Aphria'saverage media sentiment score.

Company	Overall Sentiment
Nuvo Pharmaceuticals	Neutral
Aphria	Neutral

1.8% of Nuvo Pharmaceuticals shares are owned by institutional investors. Comparatively, 8.1% of Aphria shares are owned by institutional investors. 6.3% of Nuvo Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Nuvo Pharmaceuticals beats Aphria on 6 of the 11 factors compared between the two stocks.

How does Aphria compare to Valeant Pharmaceuticals International?

Valeant Pharmaceuticals International (TSE:VRX) and Aphria (TSE:APH) are both large-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, institutional ownership, risk, earnings, analyst recommendations, dividends, media sentiment and profitability.

In the previous week, Valeant Pharmaceuticals International's average media sentiment score of 0.00 equaled Aphria'saverage media sentiment score.

Company	Overall Sentiment
Valeant Pharmaceuticals International	Neutral
Aphria	Neutral

8.1% of Aphria shares are held by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Aphria has higher revenue and earnings than Valeant Pharmaceuticals International.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Valeant Pharmaceuticals International	N/A	N/A	N/A	N/A	N/A
Aphria	C$29.01B	1.02	C$4.92B	C$4.00	6.01

Company	Net Margins	Return on Equity	Return on Assets
Valeant Pharmaceuticals International	N/A	N/A	N/A
Aphria	N/A	N/A	N/A

Summary

Aphria beats Valeant Pharmaceuticals International on 2 of the 2 factors compared between the two stocks.

How does Aphria compare to Aphria?

Aphria (TSE:APH) and Aphria (TSE:APHA) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, profitability, media sentiment, earnings, analyst recommendations and dividends.

Company	Net Margins	Return on Equity	Return on Assets
Aphria	N/A	N/A	N/A
Aphria	N/A	N/A	N/A

In the previous week, Aphria's average media sentiment score of 0.00 equaled Aphria'saverage media sentiment score.

Company	Overall Sentiment
Aphria	Neutral
Aphria	Neutral

Aphria has higher revenue and earnings than Aphria. Aphria is trading at a lower price-to-earnings ratio than Aphria, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aphria	C$29.01B	1.02	C$4.92B	C$4.00	6.01
Aphria	C$611.06M	0.00	-C$637.39M	-C$2.01	N/A

8.1% of Aphria shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Aphria beats Aphria on 5 of the 5 factors compared between the two stocks.

How does Aphria compare to Bausch Health Companies?

Bausch Health Companies (TSE:BHC) and Aphria (TSE:APH) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, risk, institutional ownership, profitability and analyst recommendations.

10.5% of Bausch Health Companies shares are owned by institutional investors. Comparatively, 8.1% of Aphria shares are owned by institutional investors. 11.3% of Bausch Health Companies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Aphria has a net margin of 0.00% compared to Bausch Health Companies' net margin of -12.02%. Bausch Health Companies' return on equity of 87.57% beat Aphria's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bausch Health Companies	-12.02%	87.57%	4.16%
Aphria	N/A	N/A	N/A

In the previous week, Bausch Health Companies had 26 more articles in the media than Aphria. MarketBeat recorded 26 mentions for Bausch Health Companies and 0 mentions for Aphria. Bausch Health Companies' average media sentiment score of 0.09 beat Aphria's score of 0.00 indicating that Bausch Health Companies is being referred to more favorably in the media.

Company	Overall Sentiment
Bausch Health Companies	Neutral
Aphria	Neutral

Aphria has higher revenue and earnings than Bausch Health Companies. Bausch Health Companies is trading at a lower price-to-earnings ratio than Aphria, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bausch Health Companies	C$10.85B	0.33	-C$125.65M	-C$2.94	N/A
Aphria	C$29.01B	1.02	C$4.92B	C$4.00	6.01

Bausch Health Companies has a beta of 0.973491, suggesting that its stock price is 3% less volatile than the broader market. Comparatively, Aphria has a beta of 3.455044, suggesting that its stock price is 246% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bausch Health Companies	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Aphria	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Bausch Health Companies and Aphria tied by winning 7 of the 14 factors compared between the two stocks.

How does Aphria compare to Cronos Group?

Aphria (TSE:APH) and Cronos Group (CVE:MJN) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, dividends, valuation, media sentiment, analyst recommendations, earnings and institutional ownership.

Aphria has higher revenue and earnings than Cronos Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aphria	C$29.01B	1.02	C$4.92B	C$4.00	6.01
Cronos Group	N/A	N/A	N/A	N/A	N/A

8.1% of Aphria shares are held by institutional investors. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Aphria's average media sentiment score of 0.00 equaled Cronos Group'saverage media sentiment score.

Company	Overall Sentiment
Aphria	Neutral
Cronos Group	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Aphria	N/A	N/A	N/A
Cronos Group	N/A	N/A	N/A

Aphria pays an annual dividend of C$0.03 per share and has a dividend yield of 0.1%. Cronos Group pays an annual dividend of C$1.65 per share and has a dividend yield of 13.6%. Aphria pays out 0.7% of its earnings in the form of a dividend.

Summary

Aphria and Cronos Group tied by winning 2 of the 4 factors compared between the two stocks.

Get Aphria News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding APH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

APH vs. The Competition

Export

Metric	Aphria	Pharmaceuticals Industry	Healthcare Sector	TSE Exchange
Market Cap	C$29.55B	C$11.72B	C$6.85B	C$12.25B
Dividend Yield	0.15%	2.72%	2.59%	6.20%
P/E Ratio	6.01	799.05	282.30	33.59
Price / Sales	1.02	753.67	564.25	9.16
Price / Cash	N/A	14.82	28.60	82.29
Price / Book	N/A	10.35	10.98	4.33
Net Income	C$4.92B	C$2.82B	C$3.49B	C$299.09M
7 Day Performance	8.00%	-0.10%	-0.60%	-0.53%
1 Month Performance	-4.76%	-3.95%	-5.19%	-1.72%
1 Year Performance	N/A	156.15%	62.02%	32.66%

Aphria Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
APH Aphria	N/A	C$24.02 flat	N/A	N/A	C$29.55B	C$29.01B	6.01	80,000	Gap Up
MRV Nuvo Pharmaceuticals	N/A	C$31.24 +4.8%	N/A	N/A	C$28.04B	C$8.72B	10.74	N/A	Gap Up
VRX Valeant Pharmaceuticals International	N/A	N/A	N/A	N/A	C$10.76B	N/A	N/A	N/A
APHA Aphria	N/A	N/A	N/A	N/A	C$5.24B	C$611.06M	N/A	1,200
BHC Bausch Health Companies	0.8519 of 5 stars	C$9.32 +10.6%	N/A	+22.3%	C$3.48B	C$10.85B	N/A	19,900	Earnings Report Gap Up High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (TSE:APH) was last updated on 8/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aphria (APH) Competitors

APH vs. MRV, VRX, APHA, BHC, and MJN

How does Aphria compare to Nuvo Pharmaceuticals?

Summary

How does Aphria compare to Valeant Pharmaceuticals International?

Summary

How does Aphria compare to Aphria?

Summary

How does Aphria compare to Bausch Health Companies?

Summary

How does Aphria compare to Cronos Group?

Summary

New MarketBeat Followers Over Time

APH vs. The Competition

Aphria Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Aphria (APH) Competitors

APH vs. MRV, VRX, APHA, BHC, and MJN

How does Aphria compare to Nuvo Pharmaceuticals?

Which has stronger earnings and valuation, MRV or APH?

Which has more volatility and risk, MRV or APH?

Is MRV or APH more profitable?

Does the media refer more to MRV or APH?

Do institutionals & insiders hold more shares of MRV or APH?

Summary

How does Aphria compare to Valeant Pharmaceuticals International?

Does the media refer more to VRX or APH?

Do insiders & institutionals believe in VRX or APH?

Which has higher earnings and valuation, VRX or APH?

Is VRX or APH more profitable?

Summary

How does Aphria compare to Aphria?

Is APH or APHA more profitable?

Does the media favor APH or APHA?

Which has stronger earnings and valuation, APH or APHA?

Do institutionals & insiders believe in APH or APHA?

Summary

How does Aphria compare to Bausch Health Companies?

Do institutionals & insiders hold more shares of BHC or APH?

Is BHC or APH more profitable?

Does the media favor BHC or APH?

Which has higher earnings and valuation, BHC or APH?

Which has more risk & volatility, BHC or APH?

Do analysts rate BHC or APH?

Summary

How does Aphria compare to Cronos Group?

Which has better valuation & earnings, APH or MJN?

Do insiders & institutionals believe in APH or MJN?

Does the media refer more to APH or MJN?

Is APH or MJN more profitable?

Is APH or MJN a better dividend stock?

Summary

New MarketBeat Followers Over Time

APH vs. The Competition

Aphria Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools